When it comes to dividend investing, there are two basic paths you can take. If you can't decide which dividend investing ...

AbbVie has announced its second major takeover ... due to read out next year, and tavapadon, a dopamine D1/D5 partial agonist in phase 3 testing as a treatment for Parkinson’s disease.

If you want to know who really controls AbbVie Inc. (NYSE:ABBV), then you'll have to look at the makeup of its share registry. With 73% stake, institutions possess the maximum shares in the company.

Plus: Inflation fears, nonfarm payrolls, and Tesla. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

Global corporate borrowing surged to a record in 2024 as companies took advantage of increased investor demand and low borrowing costs to issue a mountain of new debt. According to LSEG data cited ...

This page features the latest news about the Abbvie stock. AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call NORTH CHICAGO, Ill., Jan. 3, 2025 /PRNewswire/ -- AbbVie (NYSE ...

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and ...

A New York appellate court on Tuesday denied President-elect Donald Trump's bid to halt sentencing set for Friday for his conviction on criminal charges stemming from hush money paid to a porn ...